• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

作者信息

Slayton R E, Blessing J A, Homesley H D

出版信息

Cancer Treat Rep. 1984 Dec;68(12):1513-4.

PMID:6509456
Abstract
摘要

相似文献

1
Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Cancer Treat Rep. 1984 Dec;68(12):1513-4.
2
Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study.
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2089-92.
3
Teniposide in squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.替尼泊苷治疗子宫颈鳞状细胞癌：妇科肿瘤学组的一项II期试验
Cancer Treat Rep. 1987 Sep;71(9):873-4.
4
Phase II trial of etoposide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.依托泊苷治疗晚期或复发性子宫内膜癌的II期试验：一项妇科肿瘤学组研究
Cancer Treat Rep. 1982 Aug;66(8):1669-71.
5
Phase II trial of etoposide in the management of advanced or recurrent squamous cell carcinoma of the vulva and carcinoma of the vagina: a Gynecologic Oncology Group Study.
Cancer Treat Rep. 1987 Sep;71(9):869-70.
6
Phase II trial of AMSA in patients with advanced or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Cancer Treat Rep. 1983 Feb;67(2):197-8.
7
Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.口服依托泊苷治疗复发性或晚期子宫颈鳞状细胞癌：一项妇科肿瘤学组研究
Gynecol Oncol. 1998 Aug;70(2):263-6. doi: 10.1006/gyno.1998.5097.
8
Phase II clinical trial of diaziquone in the treatment of patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.氮烯醌治疗复发性宫颈鳞状细胞癌患者的II期临床试验：一项妇科肿瘤学组研究
Cancer Treat Rep. 1986 Sep;70(9):1127-8.
9
VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lung.
Cancer Treat Rep. 1978 May;62(5):843-4.
10
Phase II trial of menogaril in patients with squamous carcinoma of the cervix: a Gynecologic Oncology Group study.美诺加 ril 治疗子宫颈鳞状细胞癌患者的 II 期试验：一项妇科肿瘤学组研究。
Gynecol Oncol. 1994 Feb;52(2):229-31. doi: 10.1006/gyno.1994.1036.

引用本文的文献

1
Immune checkpoint inhibitors in gynecologic oncology: Current status and perspectives.妇科肿瘤学中的免疫检查点抑制剂：现状与展望
Int J Gynaecol Obstet. 2025 Sep;171 Suppl 1:166-188. doi: 10.1002/ijgo.70280.
2
A screening of a library of T7 phage-displayed peptide identifies E2F-4 as an etoposide-binding protein.T7 噬菌体展示肽文库筛选发现 E2F-4 是依托泊苷结合蛋白。
Molecules. 2011 May 24;16(5):4278-94. doi: 10.3390/molecules16054278.
3
Chemotherapy for advanced or recurrent carcinoma of the cervix.晚期或复发性宫颈癌的化疗
Curr Oncol Rep. 2001 Jan;3(1):33-40. doi: 10.1007/s11912-001-0040-5.
4
Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.依托泊苷。对其药效学和药代动力学特性以及在癌症联合化疗中的治疗潜力的综述。
Drugs. 1990 Mar;39(3):438-90. doi: 10.2165/00003495-199039030-00008.